il's recommendation that governments, including the U.S. and European Union, develop harmonized approaches to assessing the risks of endocrine disruptors.Screening Under WayWhile policy discussions continue, some companies already are providing the agency with toxicity information in the first, or screening, phase of the EPA's Endocrine Disruptor Screening Program, which is designed to detect poss